Skip to main content

News


September 8, 2021
Tactile Medical Announces Acquisition of AffloVest®
Further expands the Company’s position as a leader in treating patients with underserved chronic conditions in the home Transaction aligns with Tactile Medical’s growth & margin goals, including 20%+ revenue growth, gross margins above 70% and expanding adjusted EBITDA margins MINNEAPOLIS , Sept.
August 31, 2021
Tactile Medical to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
MINNEAPOLIS , Aug. 31, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Morgan
August 4, 2021
Tactile Medical to Present at the Guggenheim 2021 MedTech Disruptors Summit
MINNEAPOLIS , Aug. 04, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Guggenheim
August 2, 2021
Tactile Systems Technology, Inc. Reports Second Quarter 2021 Financial Results; Updates Full Year 2021 Outlook
Second Quarter Revenue Increased 45% Year-Over-Year; First Half Revenue Increased 19% Year-over-Year MINNEAPOLIS , Aug. 02, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the
June 29, 2021
Tactile Medical to Release Second Quarter of Fiscal Year 2021 Financial Results on August 2, 2021
MINNEAPOLIS , June 29, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today announced that second quarter of fiscal year 2021 financial
May 18, 2021
Tactile Medical to Present at the William Blair 41st Annual Growth Stock Conference
MINNEAPOLIS , May 18, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the William Blair
May 3, 2021
Tactile Systems Technology, Inc. Reports First Quarter 2021 Financial Results; Reaffirms Full Year 2021 Outlook
MINNEAPOLIS , May 03, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today reported financial results for the first quarter ended March
April 20, 2021
Tactile Medical Appoints Eric Pauls as Senior Vice President of Sales
MINNEAPOLIS , April 20, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the appointment of Eric Pauls to the position of
April 8, 2021
Tactile Medical to Release First Quarter of Fiscal Year 2021 Financial Results on May 3, 2021
MINNEAPOLIS , April 08, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today announced that first quarter of fiscal year 2021 financial
March 15, 2021
Tactile Medical Appoints Kristie Burns as Senior Vice President of Marketing & Clinical Affairs
MINNEAPOLIS , March 15, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, announced the appointment of Kristie Burns to the position of
Displaying 1 - 10 of 15